These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 12458353)

  • 21. Neuraminidase inhibitors and their role in avian and pandemic influenza.
    Crusat M; de Jong MD
    Antivir Ther; 2007; 12(4 Pt B):593-602. PubMed ID: 17944267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuraminidase inhibitors slightly beneficial for shortening flu symptoms.
    Phillips TG
    J Fam Pract; 2003 Oct; 52(10):747-8. PubMed ID: 14529590
    [No Abstract]   [Full Text] [Related]  

  • 23. [Neuraminidase inhibitor permitted. The first pill against influenza].
    MMW Fortschr Med; 2002 Oct; 144(41):56. PubMed ID: 12474367
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.
    Treanor JJ; Hayden FG; Vrooman PS; Barbarash R; Bettis R; Riff D; Singh S; Kinnersley N; Ward P; Mills RG
    JAMA; 2000 Feb; 283(8):1016-24. PubMed ID: 10697061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oseltamivir: a review of its use in influenza.
    McClellan K; Perry CM
    Drugs; 2001; 61(2):263-83. PubMed ID: 11270942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis.
    Hayden FG; Belshe R; Villanueva C; Lanno R; Hughes C; Small I; Dutkowski R; Ward P; Carr J
    J Infect Dis; 2004 Feb; 189(3):440-9. PubMed ID: 14745701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modifying clinical practices to manage influenza in children effectively.
    Glezen WP
    Pediatr Infect Dis J; 2008 Aug; 27(8):738-43. PubMed ID: 18664986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons.
    Kawai N; Ikematsu H; Iwaki N; Maeda T; Satoh I; Hirotsu N; Kashiwagi S
    Clin Infect Dis; 2006 Aug; 43(4):439-44. PubMed ID: 16838232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New diagnostic possibilities and medications. Fit for influenza?].
    Wutzler P
    MMW Fortschr Med; 2002 Nov; 144(48):18. PubMed ID: 12532540
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents.
    Whitley RJ; Monto AS
    J Infect Dis; 2006 Nov; 194 Suppl 2():S133-8. PubMed ID: 17163386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.
    Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Kashiwagi S
    J Infect; 2009 Sep; 59(3):207-12. PubMed ID: 19619898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of vaccination versus treatment of influenza in healthy adolescents and adults.
    Muennig PA; Khan K
    Clin Infect Dis; 2001 Dec; 33(11):1879-85. PubMed ID: 11692300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.
    Hayden FG; Atmar RL; Schilling M; Johnson C; Poretz D; Paar D; Huson L; Ward P; Mills RG
    N Engl J Med; 1999 Oct; 341(18):1336-43. PubMed ID: 10536125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The threatening influenza pandemic: a national store ofoseltamivir is a waste of money].
    Bonneux L
    Ned Tijdschr Geneeskd; 2005 Jul; 149(29):1619. PubMed ID: 16078769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidemiology, clinical picture, prevention and treatment of Avian influenza].
    Angelava NA; Angelava AV
    Georgian Med News; 2006 Feb; (131):69-76. PubMed ID: 16575138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influenza or flu-like infection? Diagnosis has consequences for therapy].
    MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688203
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.
    Nicholson KG; Aoki FY; Osterhaus AD; Trottier S; Carewicz O; Mercier CH; Rode A; Kinnersley N; Ward P
    Lancet; 2000 May; 355(9218):1845-50. PubMed ID: 10866439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Otitis media. A scholarly review of the evidence.
    Pappas DE; Owen Hendley J
    Minerva Pediatr; 2003 Oct; 55(5):407-14. PubMed ID: 14608264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients: results from a retrospective population-based study.
    Blumentals WA; Schulman KL
    Curr Med Res Opin; 2007 Dec; 23(12):2961-70. PubMed ID: 17939881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oral neuraminidase inhibitor and an early warning system. New weapons against influenza].
    Lange W; Vogel GE
    MMW Fortschr Med; 2003 Jan; 145(3-4):36-7. PubMed ID: 12619232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.